Yan et al., 2024 - Google Patents
New clues for postbiotics to improve host health: a review from the perspective of function and mechanismsYan et al., 2024
- Document ID
- 7417976578851782717
- Author
- Yan R
- Zeng X
- Shen J
- Wu Z
- Guo Y
- Du Q
- Tu M
- Pan D
- Publication year
- Publication venue
- Journal of the Science of Food and Agriculture
External Links
Snippet
Strain activity and stability severely limit the beneficial effects of probiotics in modulating host health. Postbiotics have emerged as a promising alternative as they can provide similar or even enhanced efficacy to probiotics, even under inactivated conditions. This review …
- 230000007246 mechanism 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sabahi et al. | Postbiotics as the new frontier in food and pharmaceutical research | |
| Nataraj et al. | Postbiotics-parabiotics: The new horizons in microbial biotherapy and functional foods | |
| Abbasi et al. | The biological activities of postbiotics in gastrointestinal disorders | |
| Aggarwal et al. | Postbiotics: From emerging concept to application | |
| Cuevas-González et al. | Postbiotics and paraprobiotics: From concepts to applications | |
| Zendeboodi et al. | Probiotic: conceptualization from a new approach | |
| De Marco et al. | Probiotic cell‐free supernatants exhibited anti‐inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS | |
| Vallejo-Cordoba et al. | Postbiotics and paraprobiotics: A review of current evidence and emerging trends | |
| Rafique et al. | Promising bioactivities of postbiotics: A comprehensive review | |
| de Almada et al. | Paraprobiotics: Evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods | |
| Balthazar et al. | The future of functional food: Emerging technologies application on prebiotics, probiotics and postbiotics | |
| Sekhon et al. | Prebiotics, probiotics and synbiotics: an overview. | |
| Fei et al. | Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota | |
| Xiao et al. | Lactic acid bacteria in health and disease | |
| Iqbal et al. | Role of probiotics in prevention and treatment of enteric infections: A comprehensive review | |
| Sharma et al. | Probiotics and prebiotics having broad spectrum anticancer therapeutic potential: recent trends and future perspectives | |
| CN108714157A (en) | Unvital material for the probiotics source for preventing and treating infection | |
| Pimentel et al. | Postbiotics: An overview of concepts, inactivation technologies, health effects, and driver trends | |
| Mehta et al. | The potential of paraprobiotics and postbiotics to modulate the immune system: A Review | |
| Abbasi et al. | Postbiotics: science, technology and applications | |
| Zhong et al. | Recent advances and potentiality of postbiotics in the food industry: Composition, inactivation methods, current applications in metabolic syndrome, and future trends | |
| Yan et al. | New clues for postbiotics to improve host health: a review from the perspective of function and mechanisms | |
| Ávila et al. | Protective effects of fecal microbiota transplantation in sepsis are independent of the modulation of the intestinal flora | |
| Hu et al. | Evaluation of Pediococcus pentosaceus strains as probiotic adjunct cultures for soybean milk post-fermentation | |
| Chen et al. | Kefir microbiota and metabolites stimulate intestinal mucosal immunity and its early development |